Press Release: "TrialReach launches new platform giving patients greater access to clinical trials"

Boston, United States - 19th Sep 2013

Today at Disruptive Innovations 2013 in Boston, TrialReach - the website that connects patients to clinical trials worldwide - is launching a new platform that dramatically reduces the time and costs required to find clinical trial participants.

One of the biggest challenges in clinical research is finding patients. It is estimated that 80% of all trials miss their deadlines, causing losses of up to $8M per drug per day and slowing up the process of getting new treatments to patients. The challenge is even greater for smaller independent medical research teams who have limited resources to promote their trials and find the patients they need.

TrialReach’s new platform offers an efficient, unique, highly scalable, and much needed solution to these problems. To make the process super simple for patients, complicated medical research protocols are converted into simple, patient-friendly interactive multimedia web pages on the go.The information is easy to understand, free of medical jargon and includes maps and pictures. Vitally, patients will have the opportunity to find out immediately if they are eligible for a trial through easy-to-use pre-screeners.

For medical researchers, they are now able to reach millions of patients in just a few clicks. Unlike other initiatives, the TrialReach platform is open and virtually free to all research teams, even to smaller biotech firms and academic institutions. The significance of lowering the barrier of entry for all researchers will transform the entire sector, as many more treatments in development will be exposed to patients in a useful and reliable manner. The platform will have immediate industry wide-impact.

“TrialReach is helping us to solve one of the biggest challenges in medical research - making it much easier for patients to find us, learn more and then volunteer to be in our clinical trials.”says Professor Steve Williams, Head of Dept, King’s College London.

The new TrialReach platform has been developed over the last three years with extensive input from patients and medical research teams worldwide and is now available for use by any research team at trialreach.com/trialmanager.

“The new TrialReach platform is a win-win for patients and clinical researchers,” says TrialReach CEO, Pablo Graiver. “Our goal is to democratize the information and access to medical research, so it can transform the whole industry and not just selected companies. TrialReach may be the only way for independent teams to find patients for their trials. We want patients to have access to all clinical trials because we don’t know which team will come up with the most effective treatment for any given condition.”

ENDS

About TrialReach - http://www.trialreach.com

TrialReach.com is an internet company that is transforming clinical trials by directly connecting patients with research organisations to make new treatments available more quickly and efficiently. For patients, TrialReach.com makes it easy to find, understand and apply for the latest trials available worldwide so they can compare options and make informed choices. For research organisations, TrialReach.com provides a new and more effective way to reach patients, tools to enable and monitor enrolment, and real-time data to improve trial design. Launched in 2010 and based in London, UK, TrialReach.com is fast-growing. The company has already secured funding of close to £3 million.

Press Contacts:

Boston - Pablo Graiver +447920045654 via sarah@trialreach.com

London - Andy Brown +447709487237 andy@trialreach.com